An announcement was made by the U.S. CDC last week, that the Bridge Access Program (BAP) would be ending earlier than originally planned. The BAP is now slated to end in August 2024 (the exact end date is unknown at this time), prior to the fall rollout of an updated COVID vaccine presentation.
At this time, we are urging providers to reach out to their under and uninsured patients to encourage vaccination prior to the no-cost vaccine becoming unavailable to them.
As more information becomes available, we will communicate it to you through our weekly updates.
The Maine Immunization Program has changed their User Agreement process.
Moving forward all users who have an active user agreement on file will not be required to renew for July 1, 2024.
Individuals with existing access to ImmPact must submit a new user agreement if changes are needed to their account (i.e. last name, email, site, user role or a new signing authority).
Any new user must submit a user agreement to gain access.
MIP will conduct user agreement audits throughout the year.
If a user has left your practice, please reach out to the ImmPact help desk to have that user terminated. If you have any questions, please reach out at 207-287-3006 or ImmPact.Support@maine.gov
The nomination period has now been extended to Tuesday, May 28!
The Immunization Champion Award will honor up to one Champion from each of the 50 U.S. states, the District of Columbia, six cities, and eight U.S. territories. This award recognizes individuals who are working at the local level. It honors those doing an exemplary job or going above and beyond to promote or foster immunizations in their communities, for both children and adults.
We look forward to receiving your nominations. Please share this information with your networks.
Nominations can be submitted through the online form. For any questions, please contact: camille.erickson@maine.gov. |
As we approach the end the season for the 2023-2024 COVID-19 vaccine, please be aware of the following changes:
-
Novavax: Latest 2023-2024 expiry is 5/31/2024.
-
Pfizer: Latest 2023-2024 expiry is 7/31/2024 (6m-4yo) and 8/31/2024 (5-11yo and 12yo+ refrigerated/never frozen).
-
Moderna: Latest 2023-2024 expiry for 6m-11yo and 12yo+ vaccines is late September.
- Moderna indicates supply sufficient to meet demand between now and when 2024-2025 vaccine is available.
- Providers may continue ordering throughout the remainder of the 2023-2024 season.
Proper Storage and Handling of Pfizer-BioNTech Covid-19 Vaccine:
- -90°C and -60°C (-130°F and -76°F) until the expiration date
- 2°C and 8°C (36°F and 46°F) for up to 10 weeks
- 8°C and 25°C (46°F and 77°F) for up to 12 hours prior to the first puncture or use.
-
Do not store in a standard freezer.
-
NOTE: The beyond-use date (10 weeks) replaces the manufacturer’s expiration date but NEVER extends it. Always use the earliest date. Do NOT use vaccine after the expiration date or beyond-use date.
-
Pfizer-BioNTech COVID-19 Vaccine beyond-use date tracking labels
Proper Storage and Handling of Moderna COVID-19 Vaccine:
- -50°C and -15°C (-58°F and 5°F) until the expiration date
- 2°C and 8°C (36°F and 46°F) for up to 30 days
- 8°C and 25°C (46°F and 77°F) for a total of 24 hours. Discard vial or syringe and unused vaccine after 24 hours.
-
NOTE: The beyond-use date (30 days) replaces the manufacturer’s expiration date but NEVER extends it. Always use the earliest date. Do NOT use vaccine after the expiration date or beyond-use date.
-
Moderna COVID-19 Vaccine beyond-use date tracking labels
Proper Storage and Handling of Novavax COVID-19 Vaccine:
- Before Puncture: 2°C and 8°C (36°F and 46°F) for up to 9 months*. Do NOT freeze.
- After 1st Puncture: 2°C and 25°C (36°F and 77°F) for up to 12 hours. Do NOT use after 12 hours. Discard vial and any unused vaccine after 12 hours.
-
Note: The beyond-use time (12 hours) replaces the manufacturer’s expiration date but NEVER extends it. Always use the earliest date. Do NOT use vaccine if the expiration date or beyond-use time has passed.
-
Novavax COVID-19 Vaccine beyond-use-date tracking labels
Please see additional guidance for COVID-19 doses that may have been stored improperly.
|
